Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?

@article{Ezziddin2012DoesTP,
  title={Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?},
  author={Samer Ezziddin and Jonas Lohmar and Charlotte Jane Yong-Hing and Amir Hossein Nodehi Sabet and Hojjat Ahmadzadehfar and Guido Matthias Kukuk and Hans-J{\"u}rgen Biersack and Stefan Guhlke and Karl Reichmann},
  journal={Clinical nuclear medicine},
  year={2012},
  volume={37 6},
  pages={e141-7}
}
PURPOSE Selection of candidates for peptide receptor radionuclide therapy (PRRT) is increasingly based on receptor positron emission tomography (PET) imaging, including the common tracer 68Ga DOTATOC. However, no studies have yet compared standardized uptake values (SUVs) and absorbed doses in this field. MATERIALS AND METHODS We retrospectively analyzed a consecutive cohort of 21 patients with 61 evaluable tumor lesions undergoing both pretherapeutic 68Ga DOTATOC-PET/CT (Biograph Duo… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
17 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…